|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net of allowance $801 and $13,031, respectively | |||||||||||||
| Inventories, net | |||||||||||||
| Fair value of derivative instruments | |||||||||||||
| Contract assets | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property, plant and equipment, net | |||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||
| Finance lease right-of-use assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Identifiable intangible assets, net | |||||||||||||
| Fair value of derivative instruments | |||||||||||||
| Deferred tax assets | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued liabilities | |||||||||||||
| Contract liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term debt, net of unamortized debt issuance cost | |||||||||||||
| Operating lease liabilities | |||||||||||||
| Finance lease liabilities | |||||||||||||
| Deferred tax liabilities | |||||||||||||
| Other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders’ equity: | |||||||||||||
| Preferred stock, ($50.0 million authorized, $0.01 par value) $0.2 million and 0.3 million shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | |||||||||||||
| Common stock, ($750.0 million shares of common stock authorized, $0.01 par value) $105.4 million and $90.2 million issued and 100.9 million and 85.8 million outstanding as of June 30, 2026, and December 31, 2025, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Treasury stock, at cost; 4.5 million and 4.5 million shares held as of June 30, 2026, and December 31, 2025, respectively | |||||||||||||
| Noncontrolling interest | |||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||
| (Accumulated deficit) Retained earnings | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||
| Common stock, shares outstanding (in shares) |
Loading...
